International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
Molecular Medicine Group, Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
FASEB J. 2024 Oct 15;38(19):e70081. doi: 10.1096/fj.202400743RR.
Rho guanine nucleotide exchange factor (RGNEF) is a guanine nucleotide exchange factor (GEF) mainly involved in regulating the activity of Rho-family GTPases. It is a bi-functional protein, acting both as a guanine exchange factor and as an RNA-binding protein. RGNEF is known to act as a destabilizing factor of neurofilament light chain RNA (NEFL) and it could potentially contribute to their sequestration in nuclear cytoplasmic inclusions. Most importantly, RGNEF inclusions in the spinal motor neurons of ALS patients have been shown to co-localize with inclusions of TDP-43, the major well-known RNA-binding protein aggregating in the brain and spinal cord of human patients. Therefore, it can be hypothesized that loss-of-function of both proteins following aggregation may contribute to motor neuron death/survival in ALS patients. To further characterize their relationship, we have compared the transcriptomic profiles of neuronal cells depleted of TDP-43 and RGNEF and show that these two factors predominantly act in an antagonistic manner when regulating the expression of axon guidance genes. From a mechanistic point of view, our experiments show that the effect of these genes on the processivity of long introns can explain their mode of action. Taken together, our results show that loss-of-function of factors co-aggregating with TDP-43 can potentially affect the expression of commonly regulated neuronal genes in a very significant manner, potentially acting as disease modifiers. This finding further highlights that neurodegenerative processes at the RNA level are the result of combinatorial interactions between different RNA-binding factors that can be co-aggregated in neuronal cells. A deeper understanding of these complex scenarios may lead to a better understanding of pathogenic mechanisms occurring in patients, where more than one specific protein may be aggregating in their neurons.
Rho 鸟嘌呤核苷酸交换因子(RGNEF)是一种鸟嘌呤核苷酸交换因子(GEF),主要参与调节 Rho 家族 GTP 酶的活性。它是一种双功能蛋白,既作为鸟嘌呤交换因子,又作为 RNA 结合蛋白。已知 RGNEF 作为神经丝轻链 RNA(NEFL)的不稳定因子发挥作用,并且它可能有助于将其隔离在核细胞质包含体中。最重要的是,在 ALS 患者的脊髓运动神经元中发现的 RGNEF 包含体与 TDP-43 的包含体共定位,TDP-43 是在人脑和脊髓中聚集的主要已知 RNA 结合蛋白。因此,可以假设这两种蛋白聚集后的功能丧失可能导致 ALS 患者运动神经元的死亡/存活。为了进一步表征它们之间的关系,我们比较了神经元细胞中 TDP-43 和 RGNEF 缺失的转录组谱,并表明这两种因子在调节轴突导向基因的表达时主要以拮抗方式发挥作用。从机制上讲,我们的实验表明,这些基因对长内含子的连续性的影响可以解释它们的作用方式。总之,我们的结果表明,与 TDP-43 共同聚集的因子的功能丧失可能以非常显著的方式潜在地影响共同调节的神经元基因的表达,可能作为疾病修饰因子。这一发现进一步强调了 RNA 水平上的神经退行性过程是不同 RNA 结合因子之间组合相互作用的结果,这些因子可以在神经元细胞中共聚集。对这些复杂情况的深入了解可能会更好地理解患者中发生的致病机制,其中神经元中可能会聚集不止一种特定的蛋白质。